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ABSTRACT
Background
Severe anaemia in children is a major public health problem in sub- Saharan Africa. Appropriate In this study we describe clinical and operational aspects of blood transfusion in children admitted to Coast Provincial General Hospital, Kenya.
Study design and methods
Observational study where over a 2-year period, demographic and laboratory data were collected on all children for whom the hospital blood bank received a transfusion request. Clinical data were obtained by retrospective review of case notes over the first year.
Results
There were 2789 requests for blood for children (median age, 1.8 years; IQR 0.6-6.6); 70% (1950) samples were crossmatched with 85% (1663/1950) issued. Ninety percent (1505/1663) were presumed transfused. Median time from laboratory receipt of request to collection of blood was 3.6 hours (IQR 1.4-12.8). Case notes of 590 children were reviewed and median pre-transfusion haemoglobin was 6.0g/dL (IQR 4.2-9.1). Ninety four percent (186) were transfused ‘appropriately’ whilst 52% (120) were transfused ‘inappropriately’.  There was significant disagreement between the clinical and laboratory diagnosis of severe anaemia (Exact McNemar’s test; p<0.0001). Anti-malarials were prescribed for 65% (259) of children who received blood transfusions but only 41% (106) of these had a positive blood film.   
Conclusion
In this setting, clinicians often order blood based on the clinical impression of ‘severe anaemia’. This has implications for laboratory workload and the blood supply itself. However, the majority children with severe anaemia were appropriately transfused. The use of anti-malarials with blood transfusions irrespective of blood film results is common practice. 


INTRODUCTION
Severe anaemia resulting in significant morbidity and mortality is common in children in sub-Saharan Africa and urgent blood transfusion is a life-saving intervention [1-4]. Blood shortages are common in low and middle-income countries (LMIC) and delays in the acquisition and administration of blood have contributed significantly to in-hospital mortality of children with severe anaemia [8]. 

International clinical transfusion guidelines for settings with limited resources are restrictive and reflect historical inadequacies in the blood supply. Since 2005, the WHO recommendation has been to reserve transfusion for those children with profound anaemia (Hb≤4 g/dL); Hb ≤10g/dL in neonates), and in those where anaemia is less severe (Hb 4-6g/dl) only when signs of critical illness are present. Whole blood transfusion of 20ml/kg is recommended (10 ml/kg of packed red cells preferred when available for children with heart failure and severe acute malnutrition (SAM)); and for children with SAMSSSAM, 10ml/kg of whole blood and furosemide (1mg/kg iv) at the start of the transfusion [5]. In contrast, in high income settings transfusion guidelines for haemoglobin thresholds in children and neonates are between 7g/dL and 12g/dL depending on the clinical context and packed red cells are routinely available and used [6, 7].  

To prevent the transmission of malaria by blood transfusion in endemic countries, international guidelines recommend donor selection and deferral strategies, or laboratory screening for malaria of all blood donations [8]. In practice, these two strategies are rarely implemented and a third approach is also recommended- the administration of malarial chemoprophylaxis after transfusion, especially to the most vulnerable i.e. pregnant women and children. [9]. The Kenya National Blood Transfusion Services (KNBTS) that was established in 2001 has adopted this policy adopted, which has not been revised in their latest guidance from 2004 [10]. In addition, blood is routinely screen for virus including human immunodeficiency virus (HIV), hepatitis B and C, and for syphilis but not for bacterial infections [10, 11].

In the past decade the establishment of national blood transfusion services with impetus from the WHO goal of African regional blood safety by 2012 and the mobilisation of voluntary, non-remunerated blood donors have significantly improved the supply and safety of blood in many countries in sub-Saharan Africa, including Kenya [11, 12]. Nevertheless, blood remains a limited and potentially hazardous resource and one that should be given in a timely and safe manner to only those that need it [13, 14]. There are few data relating to the clinical and operational aspects of paediatric blood transfusion in Kenya since the introduction of the national blood service in 2001 [3, 4, 15, 16]. The aim of this observational study was to describe clinical and laboratory practice and identify potential areas for intervention to improve the efficacy and safety of blood transfusion for children admitted to the second largest public referral hospital in Kenya.

METHODS
The study was conducted at Coast Provincial General Hospital (CPGH) in Mombasa. The Mombasa Regional Blood Transfusion Centre (RBTC), which is one of the 6 regional centres of the Kenya National Blood Transfusion Service (KNBTS), is adjacent to CPGH and has provided the hospital with whole blood since 2002. Blood supplied by the Mombasa RBTC has supplanted the hospital’s replacement donor system and blood shortages are less frequent.

All requests to the hospital laboratory for blood for transfusion for children aged less than 14 years were identified prospectively over a 24-month period. Data relating to transfusion requests, crossmatches and issues were extracted from existing hand-written ledgers in the CPGH blood bank. There was no ‘Group and Save’ option on the transfusion request form and most requests were marked ‘Urgent’. There were no paediatric blood packs and blood volumes of less than 1 unit (450ml) issued by the blood bank were drawn from a standard blood packs into a dry bag [13]. The study was undertaken from May 2005 to April 2007 and for the first 12 months, clinical case notes were sought from the hospital records department for all children for whom blood had been requested after they had been discharged or died. The hospital records department archived the notes of children who had died separately from those discharged alive. Data extraction relating to clinical case management  that included the clinician’s indication for requesting blood, the volumes of blood they requested and prescribed as well as the information of whether or not the child received the blood transfusion, was undertaken by two clinicians (OWH, JS) using a pre-defined template. 

Data were entered onto an electronic database (Epidata)[14] and exported to STATA 11.2 (StataCorp, College Station, Texas, USA) for analysis. Where the laboratory pre-transfusion haemoglobin results were recorded in the notes they were used to classify children as having severe anaemia or not according to the WHO criteria [5]. Weight-for-age z-scores (WAZ) were calculated using WHO 2006 child growth reference standards [18].

We calculated a recognised measure of the efficiency of blood ordering and utilisation - the “crossmatch-to-transfusion ratio” (C:T ratio) defined as  the number of blood units crossmatched divided by the number of units transfused [19]. We also calculated the “request-to issue ratio” (R:I ratio) as the number of blood units requested divided by the number of units transfused to assess for mismatch between clinician’s requests for blood and blood bank’s issuing of blood.

Fisher’s exact and chi-squared tests were used to compare categorical variables; continuous variables were summarised by means with 95% confidence intervals (95% CI) and differences tested for statistical significance using the Student’s t test. Non-normally distributed data were summarised using medians and interquartile ranges (IQR), and differences tested for statistical significance using the Wilcoxon-Mann-Whitney U test. We used McNemar’s test to assess agreement between clinical and laboratory diagnosis of severe anaemia.  We estimated the positive percent agreement and the negative percent agreement using the laboratory diagnosis of severe anaemia as a reference. A p-value of <0.05 was considered statistically significant.



RESULTS
From May 2005 to April 2007, there were 17558 paediatric admissions to CPGH and 2789 paediatric blood transfusion requests. Blood was crossmatched for 1950 (70%) of the requests and in 1505 cases crossmatched blood was issued from the blood bank and not returned. Therefore, 77% (1505/1950) of crossmatched blood and 54% (1505/2789) of requests for transfusion were presumed transfused (crossmatch-to-transfusion ratio, 1.3; request-to-issue ratio, 1.9). In 156 cases, crossmatched blood was collected from the blood bank but returned unused. Of the 2514 transfusion requests made to the blood bank where the blood volume for whole blood was recorded, 50% were for less than one unit, 38% were for one unit and 12% were for greater than one unit. Of the 1845 crossmatches by the blood bank where the blood volume was recorded, 45% were for the issue of either less than one unit (44%) or greater than one unit (1%) (62% vs. 45%; chi-square; p<0.0001) Fifty five percent of the blood issued by the blood bank was for 1 unit whereas only 38% of requests were for 1 unit (55% vs 38%; Fisher’s exact test; p<0.0001).  The majority of requests (50%) made were for less than 1 unit of blood. (Table1).

Despite repeated attempts, it was only possible to retrieve case notes for 590 (45%) of the 1322 children for whom blood was requested over the first 12 months of the study; 67% (396/590) of these children received a blood transfusion. A clinical diagnosis of ‘severe anaemia’ by the attending clinician was recorded in 48% (281/590) of the case notes, and 88% (248/281) of these were transfused. Of the 492 children who had a pre-transfusion haemoglobin recorded in their notes, only 66% (327/492) had severe anaemia using the WHO definition and 88% (287/327) of these were transfused (Table 2). Twenty-four percent (141/590) of children had neither a clinical nor a laboratory diagnosis of severe anaemia and 27% (38/141) of these were transfused. The median pre-transfusion haemoglobin concentration was 10.2 (IQR 6.5,13.2 g/dL) in children who were 3 months old or younger and 5.6 (IQR 4.0, 8.4 g/dL) in those over 3 months of age. 

We excluded 84 children aged less than 3 months of age and 23 children with no recorded data on ‘clinical severe anaemia’ from subsequent analyses as the WHO transfusion guidelines did not apply to this younger age group. The clinical impression of ‘severe anaemia’ was used as a proxy for the presence of one or more signs of critical illness (clinically detectable dehydration, shock, impaired consciousness, heart failure, deep laboured breathing, very high malaria parasitaemia). This clinical feature was recorded consistently and therefore allowed us to estimate adherence to WHO guidelines for transfusion (Table 3). Of the 197 children with either laboratory Hb =< 4 or, Hb 4-6 and a clinical impression of ‘severe anaemia’, 186 (94%) were transfused ‘appropriately’.  Of the 232 children with either Hb 4-6 and no ‘severe anaemia’, or Hb>6, 120 (52%) were transfused ‘inappropriately’ (Table 3).  

Time intervals from the receipt of a transfusion request to the issue of crossmatched blood were significantly shorter in those children with a clinical diagnosis of ‘severe anaemia’ compared to those without (Wilcoxon rank sum test; p=0.01), but this was not the case in those children with a laboratory diagnosis of severe anaemia (Wilcoxon rank sum test; p=0.44). There was strong evidence of disagreement between the clinical and laboratory diagnosis of severe anaemia (Exact McNemar’s test; p<0.0001). Using the laboratory diagnosis as the reference, the positive percent agreement and negative percent agreement for clinical diagnosis were 69.2% (95% CI 63.8, 74.1) and 83.2% (95% CI 75.7, 88.7) respectively (Table 4).
	
The median volume of whole blood prescribed was 200ml (IQR 150, 336), and the median volume prescribed by weight was 22.1ml/kg (IQR 20, 30) (Table 4). Eighty-one per cent (334/410) of blood volumes prescribed by clinicians were for less than one unit, and 15% (60/410) were for one unit (450ml). In 33% (118/354) of cases, clinicians requested for a larger volume of whole blood than what they had prescribed. Of blood transfusion requests made by clinicians and received in the blood bank, 66% (293/442) were for less than one unit and 27% (119/442) for one unit. Of the 367 crossmatches by the blood bank, 47% (172) were for the issue of one unit (Table 5). 

Of the 396 children whose case notes were reviewed and who were transfused, 259 (65%) were prescribed an antimalarial and of those who were prescribe anti-malarials, 106 (41%) had a positive blood film, 97 (38%) had a negative blood film and 55 (21%) had no result of a blood film recorded. Furosemide was prescribed for 318 (81%) of the children transfused and for 27 (7%) of those who were not. Of the 112 children with WAZ < -3 (indicating that they were severely underweight), 71 were transfused. Of these, one (0.5%) received 10ml/kg or less of whole blood (median 25.8ml/kg, IQR 20, 32), and 63 (77%) were prescribed furosemide (Table 2).

DISCUSSION
To our knowledge this is the first detailed description of the operational aspects of clinical and laboratory blood transfusion practice in children (N=2789) admitted to a Kenyan hospital since the Kenya National Blood Transfusion Service (KNBTS) was established in 2001. Blood transfusion is an integral part of acute paediatrics where children’s lives are saved if they receive appropriate blood transfusions in a timely manner [8]. However, it can also be a very costly intervention if done inappropriately [14, 16]. A clear understanding of these operational aspects is therefore important in improving the efficiency and delivery of this vital service.

Ninety six percent of children with laboratory-confirmed severe anaemia were transfused appropriately but there was significant over-transfusion of children who did not fulfil the criteria for transfusion (52%) i.e. 120 inappropriate transfusions in children over a period of a year. The data indicate that the clinicians were likely to be deciding to transfuse on the basis of their clinical judgement without laboratory confirmation of the level of anaemia. This may have been because they did not trust the Hb results, the results did not come back quickly enough or that they did not send the Hb tests and/or wait for the result [1, 20]. The use of pallor to screen for severe anaemia has good specificity (88-95%) but poor sensitivity (27-50%), and results in patients who are not severely anaemic receiving unnecessary transfusions [21, 22]. There is therefore a need to have quality assurance mechanisms to improve the accuracy and rapidity of Hb results available through the laboratory to clinicians. Clinicians would then, be able to demonstrate that their blood request is based on a laboratory Hb. For urgent requests this check of Hb could be done by the blood bank staff and senior staff should query clinicians about the need for transfusion if the Hb is not low enough. This would dissuade clinicians from requesting for blood based on a clinical diagnosis alone. Over-ordering of blood wastes a scarce resource as well as the blood bank staff time, which contributes to delays in crossmatching of blood. However, we recognise that the provision of a reliable rapid Hb result may not necessarily dissuade clinicians from relying on their clinical diagnosis of severe anaemia, as has been shown with the use of malaria rapid diagnostic tests and prescribing of anti-malarials for patients with negative results [23]. More research is needed to explore why and how behaviour might be changed. 

Clinicians generally prescribed blood according to the WHO recommendation of 20ml/kg, [5] but 33% of requests were for larger volumes of blood than were actually prescribed on the patient charts. This may suggest a lack of confidence between clinical and laboratory services – whereby clinicians’ expectation that the laboratory might ration the transfusion volume to be issued, leads them to increase the requested volumes in the hope of receiving an appropriate amount. Alternatively, this discrepancy may be due to the fact that blood request procedures may not have been updated in line with the WHO guidelines and therefore blood is ordered in units and not in millilitres, therefore resulting in larger volumes being requested. Training of clinicians in the indications for blood transfusions in children and improved communication and working relations between clinicians and blood bank staff through a hospital transfusion committee might be a possible solution to this. [24] 

The discrepancy between the volumes of blood requested by clinicians and those crossmatched by blood bank is likely to be related to the lack of paediatric packs. The blood bank is probably, and rightly, wary of entering packs too often to withdraw aliquots of blood because of the risk of introducing infection. Although there may be additional expense associated with purchasing small volume paediatric packs, this may be offset against better matching of volume against need and therefore result in less waste. This would need to be explored in a comparative study. There are also significant risks of over-transfusion associated with this practice on wards that are often poorly staffed with a lack of burettes to aid with monitoring the volumes of blood being transfused to the children. However, there is some evidence that that the current WHO blood transfusion recommendations of 20 mL/kg whole blood or 10 mL/kg packed cells may under treat a significant proportion of anaemic children but further research is required to build on this evidence [25]. 

A median request-to-issue time of between 3.6-5.4 hours is unacceptably prolonged for urgent requests for blood. This may have been due to shortages of blood or the perception of unnecessary requests for blood, leading the blood bank to wait for additional indications that the blood was really required such as a phone call or ward staff attending the blood bank in person to chase the request. This affects patient care as delays in transfusing these sick children can often lead to adverse outcomes. [25] Potential quality improvement interventions would include introducing a group and save option for clinicians supported by an agreement by the blood bank to be able to provide blood within 4 hours if it was requested and clinicians would need to understand that the sample would be unusable and therefore destroyed after a specific time had elapsed. In addition, a formal ‘urgent’ request can be introduced, whereby the blood bank would undertake to provide blood within 2 hours. Shortages of blood became less frequent with the establishment of a regional blood transfusion centre on the same campus as the hospital. 

Most of the children who were transfused received antimalarial therapy irrespective of blood film
results. As donated blood was not routinely screened for malaria in Kenya at the time of the study, clinicians would have prescribed anti-malarials in children receiving blood transfusions due to a perceived risk of transfusion-induced malaria as recommended in the Kenyan blood transfusion guidelines [24]. This practice although pragmatic, does not eliminate the risk of transfusion-induced malaria [26]. This is costly particularly in areas where there is chloroquine resistance and artemesinins have to be used [27]. It also contradicts WHO guidance about only using anti-malarials for proven malaria [5]. The routine screening of blood by the KNBTS and the emphasis in the current blood transfusion guidelines prohibiting the use of non screened blood should hopefully significantly reduce the risk of transfusion-induced malaria and therefore reduce the need to continue with this practice [28, 29]. However, there is no suitable screening test for this in the context of blood donor screening in endemic areas and eliminating malaria-positive donors is likely to have a significant effect of reducing the blood supply and therefore increasing mortality [30]. Pathogen inactivation technologies are a potential solution for the future [31].  

More research is needed about how to change the behaviour of clinicians to comply with these changes (e.g. education, better supervision of transfusion practice, blood bank being able to query requests), how to establish and maintain transfusion committees and the cost-effectiveness of introducing specialist transfusion practitioners.  

This study has a number of limitations. As we were not able to access the clinical records of all the children who had had a request for blood and there was separate archiving of records of those children that died, we were not able to estimate the overall survival or mortality outcomes in relation to the timing and receipt of blood transfusions. In addition, the recording of clinical data in the records was often incomplete resulting in missing data, which we have highlighted in our results. This data is also 8-10 years old however, it is still relevant to the current operational aspects of paediatric blood transfusions in hospital in Kenya where blood remains scarce, as the demand is often greater than the supply with a decrease in blood donors [10]. In addition, the KNBTS guidelines have not been updated since 2004 and therefore transfusion transmitted malaria remains a risk as screening of blood for malaria parasites is still not national policy and the recommendation remains to give antimalarial drugs to recipients of blood shortly after receiving the transfusion [10]. In addition, we have been able to highlight important areas for intervention that could significantly improve the processes for paediatric blood transfusions at the clinical-blood bank interface in this hospital and other hospitals facing similar challenges in the region. 

CONCLUSION AND RECOMMENDATIONS
Our data suggest that in a setting with a high demand for paediatric transfusion but historically poor
supply, clinicians tend to over-order blood both in terms of the number of requests and volumes
requested. This has implications for laboratory workload and the blood supply itself. This study provides information on areas that need to be strengthened within the system for paediatric blood transfusions in this large referral hospital in Kenya and recommendations that can help improve the efficacy and safety of blood transfusions for children in hospitals in Kenya and the region. This will ultimately improve the survival of very sick children who present to hospitals and require this life saving intervention.
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